News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

bioMerieux SA and Shanghai Kehua Bio-Engineering Build Joint Venture



1/31/2008 8:51:36 AM

SHANGHAI, China & MARCY L'ETOILE, France--(BUSINESS WIRE)--Regulatory News: Shanghai Kehua Bio-engineering (Stock Code: 002022) and bioMérieux (Paris:BIM) announce the creation of a Shanghai-based joint venture to which bioMérieux will transfer microplate immunoassay manufacturing currently located at its Boxtel site in the Netherlands.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES